RedHill Biopharma (RDHL) FCF Margin (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly FCF Margin of 18.92% for Q4 2022, up 4839.0% year-over-year from 0.38% in Q4 2021, and up 44.72% quarter-over-quarter from 34.22% in Q3 2022.
RedHill Biopharma (RDHL) FCF Margin (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported FCF Margin for 11 consecutive years, with 18.92% the latest figure, recorded in Q4 2022.
- In Q4 2022, FCF Margin rose 4839.0% year-over-year to 18.92%; the TTM figure through Jun 2023 stood at 23.58% (up 4886.0% YoY), while the FY2025 annual figure was 3372.73%, down 325635.0% from the prior year.
- FCF Margin grew to 18.92% in Q4 2022 per RDHL's latest filing, from 34.22% in the prior quarter.
- Across five years, FCF Margin topped out at 18.92% in Q4 2022 and bottomed at 983.14% in Q1 2020.
- Historically, FCF Margin has averaged 297.97% across 5 years, with a median of 88.72% in 2021.
- On a YoY basis, FCF Margin climbed as much as 163564 bps in 2018 and fell as far as 20682785 bps in 2018.
- RedHill Biopharma's FCF Margin stood at 602.58% in 2018, then slumped by 44 bps to 870.19% in 2019, then jumped by 93 bps to 58.97% in 2020, then decreased by 14 bps to 67.31% in 2021, then soared by 72 bps to 18.92% in 2022.
- Business Quant data shows RDHL's FCF Margin at 18.92% in Q4 2022, 34.22% in Q3 2022, and 89.49% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -18.92% |
| Sep 30, 2022 | -34.22% |
| Jun 30, 2022 | -89.49% |
| Mar 31, 2022 | -31.61% |
| Dec 31, 2021 | -67.31% |
| Sep 30, 2021 | -87.94% |
| Jun 30, 2021 | -87.88% |
| Mar 31, 2021 | -59.19% |
| Dec 31, 2020 | -58.97% |
| Sep 30, 2020 | -43.00% |
| Jun 30, 2020 | -71.82% |
| Mar 31, 2020 | -983.14% |
| Dec 31, 2019 | -870.19% |
| Sep 30, 2019 | -634.76% |
| Jun 30, 2019 | -660.59% |
| Mar 31, 2019 | -433.33% |
| Dec 31, 2018 | -602.58% |
| Sep 30, 2018 | -379.37% |
| Jun 30, 2018 | -357.32% |
| Mar 31, 2018 | -387.85% |